Cefdinir丨CAS 91832-40-5

Cefdinir丨CAS 91832-40-5
Product Introduction:
Catalog No.: SS114332
CAS No.: 91832-40-5
Assay(on anhydrous)/Grade: 94.0% min/CP2020
Product Name: Cefdinir
Certifications: ISO9001
Molecular Formula: C14H13N5O5S2
Molecular Weight: 395.42
Synonym(s): 8-2-(2-amino-1,3-thiazol-4-yl)-1-hydroxy-2-nitroso-ethenylamino-4-ethenyl-7-oxo-2-thia-6-azabicyclo4.2.0oct-4-ene-5-carboxylicacid
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of cefdinir丨cas 91832-40-5 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications of Cefdinir丨91832-40-5

 

Grade:

CP2020

Characteristics:

Faintly yellow to yellow crystalline powder, slight odour

Assay:

94.0% min (on anhydrous)

Identification:

IR, HPLC Complies

Crystalline:

Complies

Specific Rotation:

-58° ~ -66°

Specific absorbance:

570 ~ 610

pH:

2.5 ~ 4.5

Water:

2.0% max

Residue on ignition:

0.2% max

Heavy metals:

10 ppm max

Tetrahydrofuran:

0.072% max

Methylene chloride:

0.06% max

Triethylamine:

0.032% max

Acetic acid:

0.5% max

Ethanol:

0.5% max

Impurity A:

0.5% max

Impurity B:

0.2% max

Impurity C:

0.2% max

Impurity D:

0.2% max

Impurity E:

0.5% max

Impurity F:

0.5% max

Impurity O:

0.2% max

Impurity P:

0.5% max

Impurity Q:

0.5% max

Impurity R:

0.5% max

Impurity S:

0.5% max

Impurity T:

0.5% max

Impurity U:

0.5% max

Impurities G + H:

0.7% max

Impurities I + J + K + L:

0.7% max

Impurities M + N:

0.7% max

Any Individual impurity:

0.2% max

Total impurities:

3.0% max

Total Microbial count:

1000 CFU/g max

Moulds and yeasts:

100 CFU/g max

Escherichia Coli:

ND

Overview

 

Cefdinir丨91832-40-5 is a broad-spectrum, third-generation cephalosporin used primarily as an oral antibiotic for treating various bacterial infections. It exhibits strong activity against Gram-positive and Gram-negative bacteria, making it a valuable option in outpatient settings.

 

Applications of Cefdinir丨91832-40-5

 

1. Treatment of Respiratory Tract Infections
Cefdinir丨91832-40-5 is commonly prescribed for:
● Acute bacterial otitis media (middle ear infection)
● Pharyngitis/tonsillitis (caused by Streptococcus pyogenes)
● Sinusitis
● Acute exacerbations of chronic bronchitis
● Community-acquired pneumonia
It is particularly effective against common respiratory pathogens such as:
● Streptococcus pneumoniae
● Haemophilus influenzae
● Moraxella catarrhalis

2. Skin and Soft Tissue Infections
● Used to treat uncomplicated skin and skin structure infections (SSSIs), such as:
oCellulitis
oImpetigo
oWound infections
● Active against Staphylococcus aureus and Streptococcus pyogenes, which are common causative agents.

3. Pediatric and Geriatric Use
● Frequently used in pediatric populations, especially for ear and throat infections, due to its pleasant taste in suspension form and favorable safety profile.
● Also suitable for elderly patients, as it has good oral bioavailability and can often eliminate the need for injectable antibiotics.

 

Benefits of Cefdinir丨91832-40-5

 

1. Broad-Spectrum Activity
● Effective against a wide range of Gram-positive and Gram-negative organisms, including β-lactamase-producing strains.
● Good alternative to penicillin and older cephalosporins when resistance is suspected.
2. Oral Administration
● Available as oral capsules and powder for oral suspension, making it ideal for outpatient use and pediatric care.
● Eliminates the need for intravenous antibiotics in many cases.
3. Good Tolerability and Safety Profile
● Generally well-tolerated, with most adverse effects being mild and self-limited.
● Less likely to cause allergic reactions compared to penicillin.
4. Convenient Dosing
● Typically administered once or twice daily, depending on the indication.
● Short treatment duration (usually 5–10 days) increases patient compliance.

 

Pharmacokinetics and Mechanism of Action
● Mechanism: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
● Absorption: Oral bioavailability ~20-25%; absorption reduced by antacids or iron-containing products.
● Half-life: Approximately 1.7 hours; excreted mostly unchanged in the urine.
● No hepatic metabolism, making it safe for patients with liver impairment (but dose adjustment may be required in renal impairment).

 

Conclusion
Cefdinir丨91832-40-5 is a well-established third-generation cephalosporin antibiotic that offers broad-spectrum antibacterial coverage, excellent safety, and oral dosing convenience. It's a top choice for treating respiratory, ear, throat, skin, and soft tissue infections, especially in pediatrics and outpatient care. With its high efficacy and tolerability, cefdinir remains a reliable therapeutic option in the age of growing antibiotic resistance, provided it's used judiciously and appropriately.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us